No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
SIGI240517C110000
- 0.15
- -2.50-94.34%
15min DelayClose May 10 13:19 ET
0.20High0.15Low
0.20Open2.65Pre Close11 Volume27 Open Interest110.00Strike Price170.00Turnover58.53%IV12.16%PremiumMay 17, 2024Expiry Date0.00Intrinsic Value100Multiplier4DDays to Expiry0.15Time Value100Contract SizeAmericanOptions Type0.0540Delta0.0163Gamma654.73Leverage Ratio-0.0671Theta0.0007Rho35.34Eff Leverage0.0126Vega
Intraday
- 5D
- 1D
News
Express News | Selective Insurance Group Inc : KBW Cuts Target Price to $107 From $109
Express News | Selective Insurance Group Inc : BMO Cuts Target Price to $100 From $105
Selective Insurance Group Engages Investors With Financial Update
Selective Insurance Group, Inc. (NASDAQ:SIGI) Q1 2024 Earnings Call Transcript
Earnings Call Summary | Selective Insurance(SIGI.US) Q1 2024 Earnings Conference
The following is a summary of the Selective Insurance Group, Inc. (SIGI) Q1 2024 Earnings Call Transcript:Financial Performance:Selective Insurance Group reported an operating ROE of 11.7% in Q1 2024,
Selective Insurance Group, Inc. (SIGI) Q1 2024 Earnings Call Transcript
Selective Insurance Group, Inc. (SIGI) Q1 2024 Earnings Call Transcript
Comments
Selective Insurance Group's high P/E ratio is backed by its robust growth and promising future earnings. Shareholders are optimistic about the company's future earnings and are reluctant to sell their shares.
Investors Appear Satisfied With Selective Insurance Group, Inc.'s (NASDAQ:SIGI) ProspectsThe company's satisfactory ROE and profit retention have aided steady earnings growth. Strong earnings elevation is a result of reinvesting profits, with forecasts projecting an acceleration in company's growth rate.
The rapidly growing earnings and dividends, coupled with a low payout ratio, positions SIGI favorably from a dividend perspective. These qualities suggest that the company deserves further attention from investors with a focus on dividend stocks.
Upgrades
• $AutoZone(AZO.US$ : Goldman Sachs Upgrades to Buy from Neutral - PT $2,296 (from $1,969)
• $Chewy(CHWY.US$ : Needham Upgrades to Buy from Hold - PT $55
• $National Vision(EYE.US$ : Goldman Sachs Upgrades to Buy from Neutral - PT $32 (from $31)
• $Fresenius Medical Care(FMS.US$ : Jefferies Upgrades to Buy from Underperform - PT $33.70 (from $30.30)
• $Gitlab(GTLB.US$ : Goldman Sachs Upgrades to Buy from Neutral - ...
• $AutoZone(AZO.US$ : Goldman Sachs Upgrades to Buy from Neutral - PT $2,296 (from $1,969)
• $Chewy(CHWY.US$ : Needham Upgrades to Buy from Hold - PT $55
• $National Vision(EYE.US$ : Goldman Sachs Upgrades to Buy from Neutral - PT $32 (from $31)
• $Fresenius Medical Care(FMS.US$ : Jefferies Upgrades to Buy from Underperform - PT $33.70 (from $30.30)
• $Gitlab(GTLB.US$ : Goldman Sachs Upgrades to Buy from Neutral - ...
22
Read more